Loading organizations...
Dioko Health Ventures operates as a venture capital firm, focusing its investments on seed-stage companies within the healthcare sector. The firm specializes in identifying and supporting nascent enterprises developing innovative healthcare software and software-enabled services. Its approach centers on strategic capital deployment to solutions poised to address evolving challenges and opportunities in healthcare delivery and management.
The firm was founded in 2015 by Andrew Bouldin, who brings a background rooted in healthcare venture capital, including experience as a Partner at FCA Venture Partners. Bouldin's insight stemmed from a recognition of the significant market transformation underway in healthcare, particularly the increasing reliance on technology to improve efficiency, access, and outcomes, creating a need for specialized early-stage investment.
Dioko Health Ventures partners with early-stage companies offering digital health platforms, service solutions, and other technological advancements to healthcare providers and systems. The firm’s vision is to catalyze innovation across the healthcare landscape, nurturing the growth of enterprises that promise to reshape the industry through intelligent and impactful technological applications.
Dioko Health Ventures has 3 tracked investments across 2 companies. The latest tracked deal is $27.0M Series B in SonderMind in April 2020.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Apr 1, 2020 | SonderMind | $27.0M Series B | — | Bull City Venture Partners, Draper Associates, F Prime Capital, General Catalyst, Kickstart Fund, Silverton Partners, Threshold Ventures, PAM Garside, Jonathan Bush, F Prime Capital |
| Apr 1, 2019 | SonderMind | $3.0M Series A | Dioko Health Ventures | Draper Associates, F Prime Capital, Kickstart Fund, Silverton Partners, Threshold Ventures, PAM Garside, Jonathan Bush, Crawley Ventures, Lanoha Ventures, Notley Ventures, Preview Ventures |
| Jun 1, 2016 | RubiconMD | $4.0M Series A | Robbie Greenglass | Mundi Ventures |